Evaluation of genetic melanoma vaccines in cdk4‐mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin
暂无分享,去创建一个
M. Barbacid | M. Malumbres | C. Huber | D. Tormo | T. Tüting | J. Wenzel | T. Wölfel | J. Steitz | Stefanie Büchs | Aleix Ferrer
[1] T. Bieber,et al. Enhanced type I interferon signalling promotes Th1‐biased inflammation in cutaneous lupus erythematosus , 2005, The Journal of pathology.
[2] T. Tüting,et al. Peripheral CD8+ T cell tolerance against melanocytic self-antigens in the skin is regulated in two steps by CD4+ T cells and local inflammation: implications for the pathophysiology of vitiligo. , 2005, The Journal of investigative dermatology.
[3] S. Rosenberg,et al. Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.
[4] J. Bramson,et al. Vaccination-Induced Autoimmune Vitiligo Is a Consequence of Secondary Trauma to the Skin , 2004, Cancer Research.
[5] L. Rénia,et al. Spontaneous Vitiligo in an Animal Model for Human Melanoma , 2004, Cancer Research.
[6] J. Thompson,et al. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[7] M. Raffeld,et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.
[8] G. Hämmerling,et al. Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication. , 2002, Cancer research.
[9] A. Gambotto,et al. Genetic immunization with a melanocytic self-antigen linked to foreign helper sequences breaks tolerance and induces autoimmunity and tumor immunity , 2002, Gene Therapy.
[10] M. Barbacid,et al. Invasive melanoma in Cdk4-targeted mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[11] P. Duray,et al. Neonatal sunburn and melanoma in mice , 2001, Nature.
[12] A. Enk,et al. Genetic immunization of mice with human tyrosinase‐related protein 2: Implications for the immunotherapy of melanoma , 2000, International journal of cancer.
[13] Jonathan J. Lewis,et al. Coupling and Uncoupling of Tumor Immunity and Autoimmunity , 1999, The Journal of experimental medicine.
[14] M. Barbacid,et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia , 1999, Nature Genetics.
[15] M. Lotze,et al. Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice , 1999, Cancer Gene Therapy.
[16] A Sette,et al. Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). , 1998, Cancer research.
[17] R. Paus,et al. MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. , 1998, The Journal of investigative dermatology.
[18] P. Bruggen,et al. T cell defined tumor antigens , 1997 .
[19] S. Rosenberg. Cancer vaccines based on the identification of genes encoding cancer regression antigens. , 1997, Immunology today.
[20] N. Kirkham,et al. AN IMMUNOCYTOCHEMICAL STUDY OF MHC CLASS I EXPRESSION ON HUMAN LANGERHANS CELLS AND MELANOCYTES , 1997, The Journal of pathology.
[21] S. Rosenberg,et al. Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma , 1997, The Journal of experimental medicine.
[22] P. van der Bruggen,et al. T cell defined tumor antigens. , 1997, Current opinion in immunology.
[23] N. Hayward,et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma , 1996, Nature Genetics.
[24] M. Serrano,et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma , 1995, Science.
[25] M. Mihm,et al. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. , 1982, Journal of immunology.